TrialProceedings of the National Academy of Sciences of the United States of America2012

Efficacy of vaccination with recombinant vaccinia and fowlpox vectors expressing NY-ESO-1 antigen in ovarian cancer and melanoma patients.

Kunle Odunsi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.